Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation

Assessment first
Evidence-aware
Safety focused

Women’s Health Clinic FAQ

Can the O-Shot help with vaginal dryness?

The O-Shot may be discussed for vaginal dryness when symptoms appear linked with local tissue quality, lubrication, comfort, or low-oestrogen change, but it is not a first-line answer for every cause of dryness.

Direct answer

The O-Shot may be discussed for vaginal dryness when symptoms appear linked with local tissue quality, lubrication, comfort, or low-oestrogen change, but it is not a first-line answer for every cause of dryness.

The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.

Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation for Can the O-Shot help with vaginal dryness?
Consultation-led care

At a glance

These are the main points to understand before deciding whether this option is suitable.

At a glance

Clinical summary

What it is

An autologous (derived from the patient's own body) treatment involving the injection of Platelet-Rich Plasma (PRP).

Suitability must be confirmed after consultation.

Suitability must be confirmed after consultation.

Suitability must be confirmed after consultation.

Suitability must be confirmed after consultation.

Suitability must be confirmed after consultation.

Suitability must be confirmed after consultation.

Important safety note

Safety Profile: Because PRP is derived from the patient's own blood, the risk of allergic reaction, tissue rejection, or disease transmission is low.

Consultation
Suitability
Evidence
Safety
Aftercare




Detailed answer

Detailed answer

Investigational Status: PRP for vaginal rejuvenation is offered 'off-label' and is not specifically FDA or MHRA-approved for sexual enhancement or treating vaginal laxity.

Clinical context

Investigational Status: PRP for vaginal rejuvenation is offered 'off-label' and is not specifically FDA or MHRA-approved for sexual enhancement or treating vaginal laxity.

Mechanism
Evidence
Symptoms
Alternatives

What it means

Investigational Status: PRP for vaginal rejuvenation is offered 'off-label' and is not specifically FDA or MHRA-approved for sexual enhancement or treating vaginal laxity.

Why it happens

Symptoms may be linked to physical, hormonal, medication-related, psychological or relationship factors.

Evidence limits

Evidence may be developing, so the page should avoid promise-based language and explain uncertainty.

Treatment fit

Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.

What this means in practice

Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes).

Onset of Action: Results are not immediate because the body requires time to regenerate new tissue and blood vessels. Initial Improvements: Patients typically notice gradual changes in lubrication and tissue health between 6 to 12 weeks.





Patient safety

Why proper assessment matters

Assessment helps separate marketing claims from safe, individualised clinical decision-making.

It checks the cause

Investigational Status: PRP for vaginal rejuvenation is offered 'off-label' and is not specifically FDA or MHRA-approved for sexual enhancement or treating vaginal laxity.

It protects safety

Safety Profile: Because PRP is derived from the patient's own blood, the risk of allergic reaction, tissue rejection, or disease transmission is low.

It reviews alternatives

Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes).

It sets expectations

Onset of Action: Results are not immediate because the body requires time to regenerate new tissue and blood vessels.

A clinical decision, not a shortcut

The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.

Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.





Considerations

What to consider

Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes). Costs should be confirmed on the /pricing/ page before booking

Consultation priorities

Consultation: Begins with a comprehensive review of the patient's medical history, sexual health concerns, and suitability for the procedure.

History
Consent
Aftercare
Follow-up

Before treatment

Consultation: Begins with a comprehensive review of the patient's medical history, sexual health concerns, and suitability for the procedure.

During care

The clinician should explain the procedure, likely sensations, limits and alternatives.

Aftercare

Written aftercare and follow-up should be clear before the patient leaves.

When to reassess

If expected improvement does not occur, the plan should be reviewed rather than repeated automatically.

Practical expectations

Onset of Action: Results are not immediate because the body requires time to regenerate new tissue and blood vessels.

Costs, access and treatment plans should be confirmed before booking.





Common concerns and myths

Common misconceptions

Clear patient information should correct over-simple claims and keep expectations realistic.

Myth: Dryness is always solved by one intimate injection.

Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.

Myth: Vaginal dryness and low libido are the same problem.

Reality: results vary, evidence may be developing, and non-response should prompt reassessment.

Myth: PRP replaces proper menopause or vulval assessment.

Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.

Evidence and advertising

Marketing language should not outrun clinical evidence.

Alternatives

Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes).





Safety checklist

Safety checklist

Use these questions to decide whether treatment should be discussed, delayed or redirected.

Has the cause been assessed?

Symptoms should be reviewed in context before selecting a treatment.

Are red flags absent?

Safety Profile: Because PRP is derived from the patient's own blood, the risk of allergic reaction, tissue rejection, or disease transmission is low.

Are alternatives clear?

Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes).

Is follow-up planned?

The clinic should explain aftercare, review timing and when to seek help.

Reassuring signs

Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.

Clear goals
No red flags
Follow-up plan

Reasons to pause

Safety Profile: Because PRP is derived from the patient's own blood, the risk of allergic reaction, tissue rejection, or disease transmission is low.

Pain
Bleeding
Infection




When to escalate

When to seek medical help

Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online

Severe or worsening pain

Safety Profile: Because PRP is derived from the patient's own blood, the risk of allergic reaction, tissue rejection, or disease transmission is low.

Bleeding or discharge

Unexplained bleeding, unusual discharge or new pelvic symptoms should be reviewed.

Infection signs

Fever, spreading redness, pus or feeling unwell after a procedure needs urgent advice.

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

More clinical detail

Benchmark positioning

  • The winning page turns a commercial dryness query into a careful symptom map: what dryness feels like, what may be driving it, where PRP may fit, and when another clinical pathway is needed first.

Clinical reality

  • Investigational Status: PRP for vaginal rejuvenation is offered 'off-label' and is not specifically FDA or MHRA-approved for sexual enhancement or treating vaginal laxity.

Timeline and expectations

  • Onset of Action: Results are not immediate because the body requires time to regenerate new tissue and blood vessels.

Practical logistics

  • Procedure Time: The entire appointment, including the blood draw, centrifugation, and injection, takes less than an hour (typically 30 to 60 minutes).

Research sources

  • Willison, N. et al. (2025). Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review. J Clin Med. Chen, A. H. et al. (2025).

Next step

Book a clinical consultation

A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.

View Research Sources (12 Sources)
• Willison, N. et al. (2025). Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review. J Clin Med.
• Chen, A. H. et al. (2025). Platelet-rich plasma for genitourinary syndrome of menopause in breast cancer survivors. Obstetrics & gynaecology.
• Moccia, F. et al. (2023). Injection treatments for vulvovaginal atrophy of menopause: A systematic review. Aesthetic Plastic Surgery.
• Sacarin, G. et al. (2025). Sexual quality of life in postmenopausal women: A comparative randomised controlled trial of vaginal PRP therapy versus local hormonal treatment. Medicina.
• Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review - PubMed
• HTG581 Transvaginal laser therapy for stress urinary incontinence: Overview final - NICE
• Interventional procedure overview of transvaginal laser ... - NICE
• Atrophic Vaginitis - North Tees and Hartlepool NHS Foundation Trust
• Practical Guidance on the Use of Vaginal Laser Therapy: Focus on Genitourinary Syndrome and Other Symptoms - PMC
• Vaginal dryness - NHS
• Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice - PMC
• Rejuvenation Using Platelet-rich Plasma and Lipofilling for Vaginal Atrophy and Lichen Sclerosus - PMC

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 471 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers, evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This content is provided for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. The O-Shot is an off-label, investigational procedure. Always seek the advice of your physician or other qualified healthcare provider regarding a medical condition, treatment options, and your individual suitability before undergoing any medical procedure. Results vary. Not a cure.

Loading directory...